Farms.com Home   Ag Industry News

Tyson Foods CEO Comments on Pig Virus Impact

By Amanda Brodhagen, Farms.com

The pig-killing virus known as Porcine Epidemic Diarrhea (PED) that has been spreading across U.S. hog farms since last spring, could cut pork production by about 4 per cent in 2014, Tyson Foods CEO Donnie Smith warns.

According to Smith, PED has forced Tyson to shift its production operations to deal with tighter hog supplies. Despite smaller pork supplies, Smith expects the pork segment of its business to “perform well,” in 2014.

Smith made these comments following the release of Tyson’s second-quarter profit earnings report. The company reported a profit of $213 million, or 60 cents a share, which is up from $95 million, or 26 cents a share, from a year ago.

Highlights:

• Pork sales – were up 13% to $1.49 billion
• Chicken sales – were up 4% to $2.84 billion
• Beef sales – were up 11% to $3.83 billion (beef volume was down, but higher prices lifted the segment)
 


Trending Video

A new era in biostimulants and bionutritionals

Video: A new era in biostimulants and bionutritionals


In response to the growing need for efficient, effective biosolutions, HGS BioScience continues to expand its footprint in the bionutritional and biostimulant market with the acquisition of NutriAg, Ltd. The Paine Schwartz Partners-backed HGS BioScience is a global leader in humic and fulvic acid products. Toronto-based NutriAg is an innovator in bionutritional technologies with a deep R&D engine. North American growers and retailers will benefit from:

• Solutions across the biostimulant spectrum - including humics, fulvics, bionutritionals, carbohydrate chelation, amino acids, plant and seaweed extracts, and microbial technologies.
• A portfolio and R&D pipeline of science-backed solutions proven to drive crop productivity and farm profitability.
• Actionable nutrient insights and recommendations based on data specific to their farm and cropping goals with the NutriAnalytics platform